Altered neuroantigen-specific cytokine secretion in a Th2 environment reduces experimental autoimmune encephalomyelitis

被引:11
作者
Kirwin, Stefanie J.
Dowdell, Kenichi C.
Hindinger, Claudia
Feng, Ni
Bergmann, Cornelia C.
Hinton, David R.
Stohlman, Stephen A.
机构
[1] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA
[2] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA
[3] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA
关键词
autoimmunity; Th1/Th2; cells; EAE/MS;
D O I
10.1016/j.jneuroim.2006.05.015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Activation of Th2 cells suppresses clinical experimental autoimmune encephalitis (EAE), demyelination and expression of genes associated with Th1-mediated inflammation. Despite both reduced central nervous system inflammation and IFN-gamma induced MHC class 11 expression by microglia, the composition of CNS infiltrates in Th2-protected mice were similar to mice with EAE. Analysis of the CNS infiltrating cells by flow cytometry suggests that protection did not correlate with abrogation of CD4(+) T cell recruitment, preferential recruitment of donor Th2 cells or an increased frequency of CD25(+) CD4(+) T cells. By contrast, protection correlated with an increased frequency of neuroantigen-specific Th2 cells infiltrating the CNS. These data suggest that a peripheral Th2 cytokine environment influences both potential antigen presenting cells as well as recruitment and/or retention of neuroAg-specific Th2 CD4(+) T cells. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:30 / 39
页数:10
相关论文
共 56 条
[1]   In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines [J].
Barrat, FJ ;
Cua, DJ ;
Boonstra, A ;
Richards, DF ;
Crain, C ;
Savelkoul, HF ;
de Waal-Malefyt, R ;
Coffman, RL ;
Hawrylowicz, CM ;
O'Garra, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :603-616
[2]  
Bebo BF, 1998, J NEUROSCI RES, V52, P420, DOI 10.1002/(SICI)1097-4547(19980515)52:4<420::AID-JNR5>3.3.CO
[3]  
2-4
[4]  
Begolka WS, 1998, J IMMUNOL, V161, P4437
[5]   Perforin-mediated effector function within the central nervous system requires IFN-γ-mediated MHC up-regulation [J].
Bergmann, CC ;
Parra, B ;
Hinton, DR ;
Chandran, R ;
Morrison, M ;
Stohlman, SA .
JOURNAL OF IMMUNOLOGY, 2003, 170 (06) :3204-3213
[6]  
Bettelli E, 1998, J IMMUNOL, V161, P3299
[7]   Systemic high-dose recombinant-alpha-2a-interferon therapy modulates lymphokine production in multiple sclerosis [J].
Bongioanni, MR ;
Durelli, L ;
Ferrero, B ;
Imperiale, D ;
Oggero, A ;
Verdun, E ;
Aimo, G ;
Pagni, R ;
Geuna, M ;
Bergamasco, B .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 143 (1-2) :91-99
[8]  
BROWN AM, 1981, LAB INVEST, V45, P278
[9]  
Cannella B, 1996, J NEUROSCI RES, V45, P735, DOI 10.1002/(SICI)1097-4547(19960915)45:6<735::AID-JNR10>3.0.CO
[10]  
2-V